Previous 10 | Next 10 |
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® technology platform, today announ...
Curis Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters' Option to Purchase Additional Shares LEXINGTON, Mass. , Dec. 14, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnolo...
Should You Buy These Biotech Stocks Right Now? Biotech stocks are taking the stock market by storm again this week. This came after Greenwich Life Sciences ( GLSI Stock Report ) announced a major breakthrough in its cancer treatment candidate. The company’s poster...
Curis (CRIS) has priced its previously announced public offering of 25.6M shares at $5.75/share for gross proceeds of ~$147.5M. Underwriters have an option to purchase up to an additional 3.8M shares.Offer price represents a discount of 12% from last close price of $6.55.The offering is expec...
Curis Announces Pricing of Public Offering of Common Stock LEXINGTON, Mass. , Dec. 9, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced ...
Intec Pharma (NTEC) +111% after research pact with UK-based GW Pharma.Recon Technology (RCON) +102%.Francesca's Holdings (FRAN) +99% after receiving court approval of first day motions to support ongoing operations.ZW Data Action Technologies (CNET) +101% after opening its firs...
Curis (CRIS) to offer common stock in an underwritten public offering, and underwriters have an option to purchase additional shares in an amount of up to 15% of the shares sold.Volume, price are yet to be determined. For further details see: Curis readies equity raise
Curis Announces Proposed Public Offering of Common Stock LEXINGTON, Mass. , Dec. 8, 2020 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced its in...
The stock market has seemed unstoppable lately, and the Nasdaq Composite (NASDAQINDEX: ^IXIC) has been leading the way higher all year. The Nasdaq extended its year-to-date gains to more than 40% on Tuesday afternoon, with the index climbing about half a percent as of just before 2 ...
Gainers: Curis (CRIS) +335%.Lexicon Pharmaceuticals (LXRX) +97%.Mammoth Energy Services (TUSK) +61%.NeuroMetrix (NURO) +49%.Stitch Fix (SFIX) +45%.IGM Biosciences (IGMS) +38%.Blonder Tongue Laboratories (BDR) +26%.Infinity Pharmaceuticals (INFI) +25%.KLX Energy Services (KLXE) +24%....
News, Short Squeeze, Breakout and More Instantly...
2024-07-15 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Curis to Present at Upcoming Healthcare Conference in July PR Newswire LEXINGTON, Mass. , July 10, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IR...
2024-05-25 08:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...